Advertisement
Canadian Journal of Cardiology
Clinical Research| Volume 37, ISSUE 8, P1232-1239, August 2021

Continual Improvement in Pressure Gradient at the Lesion After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

Published:March 17, 2021DOI:https://doi.org/10.1016/j.cjca.2021.03.009

      Abstract

      Background

      Lung injury is a serious complication of balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH). Selecting a smaller balloon might minimize the occurrence of lung injury; however, it could also increase the risk of restenosis.

      Methods

      We analyzed the first target lesions in the initial BPA procedure in 34 consecutive patients with CTEPH. We measured proximal pressure with a guiding catheter and distal pressure with a pressure wire. We retrospectively investigated pressure gradients at the lesions before and immediately after the initial dilation with a smaller balloon and before the second procedure.

      Results

      The proximal pressure decreased, and the distal pressure increased immediately after the initial balloon dilation. The pressure gradient at the lesion diminished significantly by the second procedure (from 26.4 ± 10.7 to 18.2 ± 9.9 mm Hg, P < 0.001) without serious complications. The residual pressure gradient had further diminished (to 9.8 ± 6.5 mm Hg, P = 0.02) until the second procedure. The reduction in pressure gradient at the lesion from immediately after the initial balloon dilation to the second procedure was positively correlated with both the baseline mean pulmonary arterial pressure (r2 = 0.23, P = 0.004) and residual pressure gradient immediately after the initial balloon dilation (r2 = 0.58, P < 0.001).

      Conclusions

      The residual pressure gradient at the lesion diminished continually after dilation with a smaller balloon. This strategy could decrease pulmonary arterial pressure safely. It would be reasonable to dilate the lesions sequentially in 2 procedures.

      Résumé

      Contexte

      La lésion pulmonaire est une complication grave de l'angioplastie pulmonaire par ballonnet (APB) réalisée dans les cas d'hypertension pulmonaire thromboembolique chronique (HPTC). Le choix d'un ballon de plus petite taille pourrait permettre de réduire au minimum la survenue d'une lésion pulmonaire; toutefois, un tel choix pourrait aussi accroître le risque de resténose.

      Méthodologie

      Nous avons analysé les premières lésions cibles dans l'APB initiale réalisée chez 34 patients consécutifs présentant une HPTC. Nous avons mesuré la pression proximale à l'aide d'un cathéter-guide et la pression distale à l'aide d'un fil-guide à capteur de pression. Nous avons procédé à une analyse rétrospective des gradients de pression au niveau des lésions avant et immédiatement après la dilatation initiale avec un ballon plus petit et avant la seconde intervention.

      Résultats

      La pression proximale a diminué, et la pression distale a augmenté immédiatement après la dilatation initiale du ballonnet. Le gradient de pression au niveau de la lésion avait diminué de façon significative avant la seconde intervention (de 26,4 ± 10,7 à 18,2 ± 9,9 mm Hg, p < 0,001) sans complications graves. Le gradient de pression résiduel avait encore diminué (à 9,8 ± 6,5 mm Hg, p = 0,02) jusqu’à la seconde intervention. La diminution du gradient de pression au niveau de la lésion entre le moment suivant immédiatement la dilatation initiale du ballon et la seconde intervention était positivement corrélée à la pression artérielle pulmonaire moyenne au départ (r2 = 0,23, p = 0,004) et au gradient de pression résiduel immédiatement après la dilatation initiale du ballon (r2 = 0,58, p < 0,001).

      Conclusions

      Le gradient de pression résiduel au niveau de la lésion a diminué de façon continue après la dilatation avec un ballonnet de plus petite taille. Cette stratégie pourrait permettre de réduire la pression artérielle pulmonaire en toute sécurité. Il serait raisonnable de dilater les lésions en deux interventions séquentielles.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Feinstein JA
        • Goldhaber SZ
        • Lock JE
        • Ferndandes SM
        • Landzberg MJ
        Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.
        Circulation. 2001; 103: 10-13
        • Mizoguchi H
        • Ogawa A
        • Munemasa M
        • Mikouchi H
        • Ito H
        • Matsubara H
        Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension.
        Circ Cardiovasc Interv. 2012; 5: 748-755
        • Kataoka M
        • Inami T
        • Hayashida K
        • et al.
        Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension.
        Circ Cardiovasc Interv. 2012; 5: 756-762
        • Olsson KM
        • Wiedenroth CB
        • Kamp JC
        • et al.
        Balloon pulmonary angioplasty for inoperable Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience.
        Eur Respir J. 2017; 491602409
        • Brenot P
        • Jaïs X
        • Taniguchi Y
        • et al.
        French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
        Eur Respir J. 2019; 531802095
        • Ejiri K
        • Ogawa A
        • Fujii S
        • Ito H
        • Matsubara H
        Vascular injury is a major cause of lung injury after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
        Circ Cardiovasc Interv. 2018; 11e005884
        • Shimokawahara H
        • Ogawa A
        • Mizoguchi H
        • Yagi H
        • Ikemiyagi H
        • Matsubara H
        Vessel stretching is a cause of lumen enlargement immediately after balloon pulmonary angioplasty: intravascular ultrasound analysis in patients with chronic thromboembolic pulmonary hypertension.
        Circ Cardiovasc Interv. 2018; 11e006010
        • Rodriguez AE
        • Rodriguez Alemparte M
        • Fernandez Pereira C
        • et al.
        Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): Immediate and long-term results.
        Am Heart J. 2005; 150: 188
        • Nagayoshi S
        • Ogawa A
        • Matsubara H
        Spontaneous enlargement of pulmonary artery after successful balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension.
        EuroIntervention. 2016; 12: e1435
        • Kawakami T
        • Ogawa A
        • Miyaji K
        • et al.
        Novel angiographic classification of each vascular lesion in chronic thromboembolic pulmonary hypertension based on selective angiogram and results of balloon pulmonary angioplasty.
        Circ Cardiovasc Interv. 2016; 9e003318
        • Kitani M
        • Ogawa A
        • Sarashina T
        • Yamadori I
        • Matsubara H
        Histological changes of pulmonary arteries treated by balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension.
        Circ Cardiovasc Interv. 2014; 7: 857-859
        • Ogawa A
        • Kitani M
        • Mizoguchi H
        • et al.
        Pulmonary microvascular remodeling after balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension.
        Intern Med. 2014; 53: 729-733
        • Lang I
        • Meyer BC
        • Ogo T
        • et al.
        Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
        Eur Respir Rev. 2017; 26160119
        • Baek SH
        • Hrabie JA
        • Keefer LK
        • et al.
        Augmentation of intrapericardial nitric oxide level by a prolonged-release nitric oxide donor reduces luminal narrowing after porcine coronary angioplasty.
        Circulation. 2002; 105: 2779-2784